MARC details
| 000 -LEADER |
| fixed length control field |
04546nam a22004455i 4500 |
| 001 - CONTROL NUMBER |
| control field |
991032868602419 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
GHU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20260524114820.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
| fixed length control field |
m || d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
200114s2020 |||||||eo |||| ||eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
| LC control number |
(WlAbNL)991032868602419 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780323654326 |
| Qualifying information |
(PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0323654320 |
| Qualifying information |
(PDF) |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(WlAbNL)(Uk)ark:/81055/vdc_100095975671.0x000001 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(WlAbNL)(Uk)019676243 |
| 037 ## - SOURCE OF ACQUISITION |
| Stock number |
9780323654326 |
| Source of stock number/acquisition |
Ingram Content Group |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
Uk |
| Language of cataloging |
eng |
| Transcribing agency |
GHU |
| Modifying agency |
GHULIB |
| 050 10 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RM121 MCC |
| 100 10 - MAIN ENTRY--PERSONAL NAME |
| Personal name |
McCuistion, Linda E. |
| Relator term |
author |
| Affiliation |
NCLEX® Live Review Presenter, Mandeville, Louisiana |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2002012237 |
| Real World Object URI |
http://viaf.org/viaf/78133395 |
| 245 10 - TITLE STATEMENT |
| Title |
Pharmacology - E-Book : |
| Remainder of title |
A Patient-Centered Nursing Process Approach / |
| Statement of responsibility, etc. |
Linda E. McCuistion, Jennifer J. Yeager, Mary B. Winton, Kathleen Vuljoin DiMaggio. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
10th |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Name of producer, publisher, distributor, manufacturer |
Saunders, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2020. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource (1024 pages) |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Source |
rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Unit 1: Introduction to Pharmacology 1.The Nursing Process and Patient-Centered Care 2.Drug Development and Ethical Considerations 3.Pharmacokinetics and Pharmacodynamics 4.Pharmacogenetics 5.Complementary and Alternative Therapies 6.Pediatric Considerations 7.Geriatric Considerations 8.Drugs in Substance Use Disorder Unit 2: Pharmacotherapy and Drug Administration 9.Safety and Quality 10.Drug Administration 11.Drug Calculations Unit 3: Maintenance of Homeostasis 12.Fluid Volume and Electrolytes 13.Vitamin and Mineral Replacement 14.Nutritional Support Unit 4: Autonomic Nervous System Drugs 15.Adrenergic Agonists and Antagonists 16.Cholinergic Agonists and Antagonists Unit 5: Central and Peripheral Nervous System Drugs 17.Stimulants 18.Depressants 19.Antiseizure Drugs 20.Drugs for Parkinsonism and Alzheimer’s Disease 21.Drugs for Neuromuscular Disorders and Muscle Spasms Unit 6: Mental and Behavioral |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Health Drugs 22.Antipsychotics and Anxiolytics 23.Antidepressants and Mood Stabilizers Unit 7: Pain and Inflammation Management Drugs 24.Antiinflammatories 25.Analgesics Unit 8: Antimicrobial Drugs 26.Antibacterials 27.Antituberculars, Antifungals, and Antivirals 28.Antimalarials, Anthelmintics, and Peptides Unit 9: Immunologic Drugs 29.HIV- and AIDS-Related Drugs 30.Transplant Drugs 31.Vaccines Unit 10: Antineoplastics and Biologic Response Modifiers 32.Anticancer Drugs 33.Targeted Therapies to Treat Cancer 34.Biologic Response Modifiers Unit 11: Respiratory Drugs 35.Upper Respiratory Disorders 36.Lower Respiratory Disorders Unit 12: Cardiovascular Drugs 37.Cardiac Glycosides, Antianginals, and Antidysrhythmics 38.Diuretics 39.Antihypertensives 40.Anticoagulants, Antiplatelets, |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
and Thrombolytics 41.Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow Unit 13: Gastrointestinal Drugs 42.Gastrointestinal Tract Disorders 43.Antiulcer Drugs Unit 14: Eye, Ear, and Skin Drugs 44.Eye and Ear Disorders 45.Dermatologic Disorders Unit 15: Endocrine Drugs 46.Pituitary, Thyroid, Parathyroid, and Adrenal Disorders 47.Antidiabetics Unit 16: Renal and Urologic Drugs 48.Urinary Disorders Unit 17: Reproductive and Gender-Related Drugs 49.Pregnancy and Preterm Labor 50.Labor, Delivery, and Postpartum 51.Neonatal and Newborn 52.Reproductive Health 53.Men’s Health and Reproductive Disorders 54.Sexually Transmitted Infections Unit 18: Sexually Transmitted Infections 55.Adult and Pediatric Emergency Drugs |
| 506 1# - RESTRICTIONS ON ACCESS NOTE |
| Terms governing access |
Legal Deposit; |
| Physical access provisions |
Only available on premises controlled by the deposit library and to one user at any one time; |
| Authorization |
The Legal Deposit Libraries (Non-Print Works) Regulations (UK). |
| Institution to which field applies |
WlAbNL |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
| Terms governing use and reproduction |
Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force. |
| Institution to which field applies |
WlAbNL |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Yeager, Jennifer J., |
| Relator term |
author. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2016190229 |
| Real World Object URI |
http://viaf.org/viaf/32148207598800340388 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Winton, Mary B., |
| Relator term |
author. |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2016190228 |
| Real World Object URI |
http://viaf.org/viaf/36148207589900340373 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Vuljoin-DiMaggio, Kathleen, |
| Relator term |
author |
| Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2016190227 |
| Real World Object URI |
http://viaf.org/viaf/29148207628900340369 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
| Suppress in OPAC |
No |
| 981 ## - EQUIVALENCE OR CROSS-REFERENCE-SERIES STATEMENT--CORPORATE NAME/TITLE [LOCAL, CANADA] |
| Corporate name or jurisdiction name as entry element |
LD-Ebook |